Prospective Observational Study on Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer in Rwanda: Acute Toxicity in Patients
MHF (20 × 3 Gy) was well tolerated in men treated for prostate cancer in Rwanda, showing that MHF is feasible in an African setting. However, further research on acute and late toxicity for more patients is warranted.
Authors
- Emmanuel Mutabazi
- Pacifique Mugenzi
- Wilma D. Heemsbergen (ORCID: https://orcid.org/0000-0003-2144-0729)
- Theoneste Maniragaba (ORCID: https://orcid.org/0000-0002-0746-3011)
- Felix Sinzabakira (ORCID: https://orcid.org/0000-0001-6544-5842)
- Fidel Rubagumya (ORCID: https://orcid.org/0000-0002-8129-5714)
- Luca Incrocci (ORCID: https://orcid.org/0000-0001-9994-763X)
- Andrea Diane Ndoli
- Claire Umubyeyi
Institutions
- Rwanda Military Hospital (RW)
- Erasmus MC Cancer Institute (NL)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1200/go-24-00311
- Citations
- 2
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.84